Outcomes of a multifactorial cardiovascular prevention programme in patients with type 2 diabetes: An observational study

被引：0
|
作者：
Finn, Y. [1 ,2 ,3 ]
Gorecka, M. [4 ]
Flaherty, G. [1 ,3 ]
Dunne, F. [1 ,2 ,3 ]
O'Brien, T. [1 ,2 ,3 ]
Crowley, J. [1 ,3 ,4 ]
Woods, D. [1 ,3 ]
Connolly, S. [3 ]
Jones, J. [3 ,5 ]
Gibson, I. [1 ,3 ]
机构：
[1] Natl Univ Ireland Galway, Sch Med, Galway, Ireland
[2] Univ Hosp Galway, Ctr Diabet Endocrinol & Metab, Galway, Ireland
[3] West Ireland Cardiac & Stroke Fdn, Natl Inst Prevent & Cardiovasc Hlth, Galway, Ireland
[4] Univ Hosp Galway, Dept Cardiol, Galway, Ireland
[5] Brunel Univ, Sch Hlth Sci & Social Care, London, England
来源：
DIABETIC MEDICINE | 2020年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P162
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [1] Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    Gaede, P
    Vedel, P
    Larsen, N
    Jensen, GVH
    Parving, H
    Pedersen, O
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05): : 383 - 393
  • [2] Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: An observational study
    McManus, Emma
    Meacock, Rachel
    Parkinson, Beth
    Sutton, Matt
    LANCET REGIONAL HEALTH-EUROPE, 2022, 19
  • [3] Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: An observational study
    McManus, Emma
    Meacock, Rachel
    Parkinson, Beth
    Sutton, Matt
    LANCET REGIONAL HEALTH-EUROPE, 2022, 19
  • [4] Smoking and cardiovascular disease in patients with type 2 diabetes: a prospective observational study
    Af Geijerstam, Peder
    Janryd, Fredrik
    Nystrom, Fredrik H.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (11) : 802 - 807
  • [5] Prevention of cardiovascular disease in patients with type 2 diabetes
    Lebherz, Corinna
    Lehrke, Michael
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (09) : 645 - U16
  • [6] Multifactorial intervention and cardiovascular disease in type 2 diabetes
    Ahmed, SA
    Manning, D
    McGurk, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19): : 1925 - 1926
  • [7] Cardiovascular prevention in diabetes mellitus: A multifactorial challenge
    Pedro-Botet, Juan
    Chillaron, Juan J.
    Benaiges, David
    Flores-Le Roux, Juana A.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (03): : 154 - 163
  • [8] SAXAGLIPTIN AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES
    Raz, I
    Scirica, B. M.
    Braunwald, E.
    Mosenzon, O.
    Hirshberg, B.
    Wiviott, S. D.
    Frederich, R.
    Davidson, J.
    Leiter, L. A.
    Bhatt, D. L.
    HYPERTENSION, 2014, 63 (06) : E167 - E167
  • [9] Cardiovascular Outcomes with Dapagliflozin for Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (03): : 262 - 264
  • [10] Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Marso, Steven P.
    Bain, Stephen C.
    Consoli, Agostino
    Eliaschewitz, Freddy G.
    Jodar, Esteban
    Leiter, Lawrence A.
    Lingvay, Ildiko
    Rosenstock, Julio
    Seufert, Jochen
    Warren, Mark L.
    Woo, Vincent
    Hansen, Oluf
    Holst, Anders G.
    Pettersson, Jonas
    Vilsboll, Tina
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1834 - 1844
12345